ALKBH5 and hepatocellular carcinoma: ALKBH5-mediated IGF2BP1-dependent m6A demethylation reduces the stability of LYPD1 mRNA, and aberrant downregulation of ALKBH5 promotes LYPD1 expression and induces oncogenic behavior of HCC [13].